| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 4.274 | 3.575 | 68.504 | 122.073 | 167.434 | 189.786 |
| Total Income - EUR | - | - | - | 0 | 4.274 | 3.575 | 68.495 | 122.145 | 175.467 | 192.954 |
| Total Expenses - EUR | - | - | - | 76 | 893 | 3.328 | 17.277 | 17.429 | 52.177 | 74.823 |
| Gross Profit/Loss - EUR | - | - | - | -76 | 3.380 | 247 | 51.217 | 104.716 | 123.290 | 118.130 |
| Net Profit/Loss - EUR | - | - | - | -76 | 3.252 | 140 | 49.162 | 101.052 | 121.535 | 113.055 |
| Employees | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Elisderma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 214.594 | 216.320 |
| Current Assets | - | - | - | 43 | 3.725 | 5.239 | 53.189 | 135.045 | 33.686 | 122.816 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 2.140 | 1.383 | 406 | 0 | 754 |
| Cash | - | - | - | 43 | 3.725 | 3.099 | 51.807 | 134.640 | 33.686 | 24.881 |
| Shareholders Funds | - | - | - | -33 | 3.220 | 3.299 | 52.388 | 101.100 | 222.329 | 334.141 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 76 | 505 | 1.941 | 802 | 33.945 | 25.951 | 5.095 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Elisderma S.r.l.